The Capitol Times in Wisconsin ran a story just before the primary there on Bernie Sanders on Stem Cells, indicating that has held anti-stem cell research positions. It can sometimes be hard to figure out politicians’ positions on stem cells and what actions they might take. Update: See this poll on what people predicted the […]
Bernie Sanders Mixed Record on Stem Cells Read More »
Stem cell clinics like Nervana are spreading like wild-fire across the U.S. A few months back the Sacramento area got a new stem cell clinic selling amniotic stem cell therapies for a variety of ills including most prominently arthritis and pain. This clinic is called Nervana Stem Cell Center. I first noticed it via a
Stem cell clinic Nervana new ad claims no side effects & FDA OK Read More »
Senators Mark Kirk, Joe Manchin, and Susan Collins have proposed new legislation in the form of the REGROW Act that would substantially interfere with the FDA’s ability to properly regulate the development of new stem cell and regenerative medicine therapies based on hard science. The REGROW Act would force the FDA to allow rushed introduction of experimental stem
REGROW Act is Attack on Science-Based Stem Cell Trial Oversight Read More »
Remember Nervana Stem Cell Center, an amniotic stem cell clinic here in the Sacramento area, which I’ve posted about before here and here. One big question about Nervana remains unanswered: is its apparent marketing of amniotic stem cells for arthritis and other conditions is OK with the FDA? Another question has been, “who are the medical
Sacramento amniotic stem cell clinic advertises again, but by another name Read More »
There’s a questionable notion floating around out there in the numerous discussions over heritable human genetic modification and CRISPR. This idea goes that if germline human gene editing goes awry for any number of reasons, scientists could simply reverse it by applying genetics again. The reversal notion does not fit with the reality of science
You can’t retract a designer baby: CRISPR, social justice, & risks Read More »
There is considerable interest in FDA regulatory reform here in the U.S. for stem cell therapies. The goal is to get new treatments to patients faster, but is there a way to do that without sacrificing proven safety and efficacy? You need convincing data on both safety and efficacy or speed becomes dangerous. Bipartisan Policy Center
Cons Outweigh Potential Pros to BPC Plan on Stem Cells & FDA Read More »
A team at the University of Miami has launched a claimed first of its kind stem cell clinic trial for Alzheimer’s Disease (AD). The trial seems somewhat unique in using mesenchymal stem cells (MSC) for AD and is being run with biotech Longeveron. You can read more on the actual clinic trial including all the
New Stem Cell Clinic Trial for Alzheimer’s: Perspectives & Questions Read More »
A couple of months back, the FDA issued a warning letter to three co-owned stem cell clinics selling fat stem cell-based interventions to patients for a variety of ills. You can read all about the warning letter here. It went to lead clinic, Irvine Stem Cell Treatment Center as well as the two co-owned clinics, which
Content Wiped on Websites of Stem Cell Clinics Warned by FDA Read More »
I blogged recently about how Sacramento has a new stem cell clinic using amniotic stem cells called Nervana Stem Cell Center. Its website currently offers no details on the people behind the company that I could find. I sent Nervana a message on their website to try to learn more based in part on a commenter on
More on Nervana Stem Cell Clinic in Sacramento Read More »
Traditional clinical trials have four phases. Each phase plays an important, unique role in testing whether new drug products are safe and effective as well as how they compare to the standard of care. Today in the stem cell field across the globe, the Phase III is under fire including what some might call friendly
Important, endangered species in stem cell medicine: the phase III trial Read More »